Pancreatic Cancer Research

ResearcherFudan University Shanghai Cancer CenterNo recent work listed

Yu Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7751-6345; OpenAlex author ID A5061742939. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers

Papers 3

  1. Long noncoding RNA XIST regulates the EGF receptor to promote TGF-β1-induced epithelial-mesenchymal transition in pancreatic cancer. Co-author DOI 10.1139/bcb-2018-0274↗
  2. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer. Co-author DOI 10.3892/or.2020.7810↗
  3. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC. Co-author DOI 10.2174/1566524015666150401102218↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juehua Yu · 2 shared papers, 2020 · strength 0.22
  2. Kunhua Wang · 2 shared papers, 2020 · strength 0.22
  3. Lei Zou · 2 shared papers, 2020 · strength 0.22
  4. Shi‐He Liu · 1 shared paper, 2020 · strength 0.10
  5. Cheng Yeh Chen · 1 shared paper, 2020 · strength 0.10
  6. Hongjin Wu · 1 shared paper, 2020 · strength 0.10
  7. Francis Charles Brunicardi · 1 shared paper, 2020 · strength 0.10
  8. Jin Xu · 1 shared paper, 2015 · strength 0.05
  9. Cheng He · 1 shared paper, 2015 · strength 0.05
  10. C. Liu · 1 shared paper, 2015 · strength 0.05
  11. Xianjun Yu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.